PD-Rx Famotidine 20mg Tablets Recall: Weight Issue
PD-Rx Pharmaceuticals recalls Famotidine 20mg tablets due to weight specification failure. Affected lots may have incorrect tablet weight.
Lower-risk recall
Failed Tablet/Capsule Specification: out of specification for tablet weight.
Contact the company
What happened, in plain English
PD-Rx Pharmaceuticals is recalling Famotidine 20mg tablets because they may weigh incorrectly. This could affect the medication's effectiveness but does not pose an immediate safety risk. Read more at govinfonow.com/recall/41423-pd-rx-famotidine-20mg-tablets-recall-weight-issue.
Source Summary by GovInfoNow · govinfonow.com/recall/41423-pd-rx-famotidine-20mg-tablets-recall-weight-issue · Updated October 7, 2026 · FDA enforcement record: FDA #D-1057-2017
Cite this page
“PD-Rx Famotidine 20mg Tablets Recall: Weight Issue.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/41423-pd-rx-famotidine-20mg-tablets-recall-weight-issue. Based on FDA recall #D-1057-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1057-2017%22&limit=1).
Why it’s dangerous
The tablets may weigh outside the specified range, which could lead to incorrect medication dosing. This might affect how well the drug works but does not cause immediate harm or injury.
Who’s affected
Prescription holders of Famotidine 20mg tablets with the specific lot number A17F55 (expiring June 30, 2018) are affected. Patients using this medication for heartburn or ulcers may be at risk of incorrect dosing.
How to tell if you have this one
Check for the lot number A17F55 on the packaging. The product is a 30-tablet bottle labeled 'Famotidine USP 20 mg, Rx, PKG' with expiration date 06/30/2018.
- Brand
PD-Rx Pharmaceuticals- Category
Drug
What to do — step by step
Check Product Details
Look for the lot number A17F55 on the packaging of the Famotidine 20mg tablets.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 4 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1057-2017 (July 28, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1057-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.